- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01143350
Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders
May 31, 2011 updated by: Centre Hospitalier Universitaire de Nice
The STIM-EHPAD study (for stimulation in nursing home) aims to evaluate the short and medium term effectiveness of staff education as a non-pharmacological intervention to manage apathy in older people with a diagnosis of dementia.
- Primary efficacy criteria: Apathy Inventory clinician score changes
- Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, France, 06001
- Robert
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients older than 65 years
- A diagnosis of dementia according to the ICD 10 criteria
- MMSE score ≤ 24
- Presenting the diagnostic criteria of apathy (cf page ??)
- An Apathy Inventory clinician total score >3 (with at least a score higher than 1 at one of the 3 dimensions; lack of initiative, lack of interest, emotional blunting)
Exclusion Criteria:
- Patients more than 65 years
- MMSE score > 24
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EHPAD Training and Stimulation
EHPAD of the group of Training / Stimulation will benefit:
|
EHPAD of the group of Training / Stimulation will benefit:
|
|
Placebo Comparator: 2- EHPAD control
EHPAD of the reference group, will have their habitual functioning
|
EHPAD of the reference group, will have their habitual functioning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.
Time Frame: 1 year
|
Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Philippe Ph ROBERT, PhD, CHU de Nice - CM2R - Hôpital de Cimiez - 4 avenue reine victoria - 06 003 Nice cedex 1
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
February 25, 2010
First Submitted That Met QC Criteria
June 11, 2010
First Posted (Estimate)
June 14, 2010
Study Record Updates
Last Update Posted (Estimate)
June 1, 2011
Last Update Submitted That Met QC Criteria
May 31, 2011
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-PP-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer's Disease
-
University of SaskatchewanCenter of Molecular Immunology, CubaNot yet recruitingMild Alzheimer's Disease | Moderate Alzheimer's DiseaseCanada
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; American Heart Association; Schaeffer...CompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); Alzheimer's Therapeutic Research Institute; Brigham and Women's Hospital and other collaboratorsCompletedDementia | Alzheimer Disease | Prodromal Alzheimer's Disease | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
University of Southern CaliforniaAlzheimer's Therapeutic Research Institute; Alzheimer's Association; Alzheimer...Active, not recruitingPreclinical Alzheimer's Disease | Early Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedTerminatedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedRecruitingAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited Kingdom
-
Novoic LimitedTerminatedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
Novoic LimitedCompletedAlzheimer Disease | Mild Cognitive Impairment | Prodromal Alzheimer's Disease | Alzheimer's Disease (Incl Subtypes) | Preclinical Alzheimer's DiseaseUnited States
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceCompletedAlzheimer's Disease (AD) | Alzheimer's Disease (AD) Related DisordersFrance
Clinical Trials on Bras A (EHPAD Training and stimulation)
-
Hospices Civils de LyonCompleted
-
Hospices Civils de LyonCompletedCovid19 | Respiratory Distress Syndrome | Ventilators, MechanicalFrance
-
Massachusetts General HospitalNational Institutes of Health (NIH); National Center for Complementary and...Completed
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria... and other collaboratorsUnknownStroke, Ischemic | Stroke HemorrhagicItaly
-
Wuhan UniversityActive, not recruitingPost-extubation DysphagiaChina
-
Centre for Addiction and Mental HealthCompleted
-
Centre for Interdisciplinary Research in Rehabilitation...MitacsNot yet recruitingSpinal Cord Injury | Gait Disorder, Sensorimotor | Gait Disorders | Locomotion | Spinal Cord Injury SubacuteCanada
-
Prof. Dr. Katrin GielCompleted
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceCompleted
-
University Hospital, Strasbourg, FranceTerminatedChronic Obstructive Pulmonary Disease | Acute Respiratory FailureFrance